Literature DB >> 12753420

Depressant effects of ambroxol and erdosteine on cytokine synthesis, granule enzyme release, and free radical production in rat alveolar macrophages activated by lipopolysaccharide.

Yoon Young Jang1, Jin Ho Song, Yong Kyoo Shin, Eun Sook Han, Chung Soo Lee.   

Abstract

The present study examined the effects of ambroxol and erdosteine, bronchial expectorants, on the cytokine synthesis, granule enzyme release, and free radical production in rat alveolar macrophages activated by lipopolysaccharide. Ambroxol and erdosteine significantly decreased the production of tumour necrosis factors-alpha, interleukin-1beta, and interleukin-6 in alveolar macrophages activated by lipopolysaccharide. These drugs significantly reduced the production of superoxide anion, hydrogen peroxide, and nitric oxide and the release of acid phosphatase and lysozyme in lipopolysaccharide-activated macrophages. Ambroxol and erdosteine showed no scavenging effect on superoxide anion and hydrogen peroxide, whereas both drugs effectively decomposed nitric oxide. The results show that ambroxol and erdosteine may inhibit the responses, including cytokine synthesis and free radical production, in rat alveolar macrophages activated by lipopolysaccharide. Unlike the production of reactive oxygen species, the inhibitory effect of ambroxol and erdosteine on the production of nitric oxide in lipopolysaccharide-activated alveolar macrophages may be accomplished by a scavenging action on the species and inhibition of the respiratory burst.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12753420     DOI: 10.1034/j.1600-0773.2003.920407.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  14 in total

1.  Effects of erdosteine on bleomycin-induced lung fibrosis in rats.

Authors:  Haşim Boyaci; Hale Maral; Gupse Turan; Ilknur Başyiğit; Meltem O Dillioğlugil; Füsun Yildiz; Melih Tugay; Ayşe Pala; Cengiz Erçin
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

2.  Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities.

Authors:  Göksel Sener; Halil Aksoy; Ozer Sehirli; Meral Yüksel; Cenk Aral; Nursal Gedik; Sule Cetinel; Berrak C Yeğen
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

3.  Ambroxol - Resurgence of an old molecule as an anti-inflammatory agent in chronic obstructive airway diseases.

Authors:  P R Gupta
Journal:  Lung India       Date:  2010-04

Review 4.  Ambroxol: a CNS drug?

Authors:  Thomas Weiser
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

5.  Anti-inflammatory Effect of Erdosteine in Lipopolysaccharide-Stimulated RAW 264.7 Cells.

Authors:  Jong Sun Park; Mi-Young Park; Young-Jae Cho; Jae Ho Lee; Chul-Gyu Yoo; Choon-Taek Lee; Sang-Min Lee
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

6.  Suppressive effects of the expectorant drug ambroxol hydrochloride on quartz-induced lung inflammation in F344 rats.

Authors:  Shohei Kanie; Masanao Yokohira; Keiko Yamakawa; Yuko Nakano-Narusawa; Shota Yoshida; Nozomi Hashimoto; Katsumi Imaida
Journal:  J Toxicol Pathol       Date:  2016-12-22       Impact factor: 1.628

7.  Effects of the expectorant drug ambroxol hydrochloride on chemically induced lung inflammatory and neoplastic lesions in rodents.

Authors:  Shota Yoshida; Masanao Yokohira; Keiko Yamakawa; Yuko Nakano-Narusawa; Shohei Kanie; Nozomi Hashimoto; Katsumi Imaida
Journal:  J Toxicol Pathol       Date:  2018-06-09       Impact factor: 1.628

Review 8.  Characteristics of surfactant proteins in tumorigenic and inflammatory lung lesions in rodents.

Authors:  Masanao Yokohira; Keiko Yamakawa; Yuko Nakano-Narusawa; Nozomi Hashimoto; Shohei Kanie; Shota Yoshida; Katsumi Imaida
Journal:  J Toxicol Pathol       Date:  2018-06-02       Impact factor: 1.628

9.  Ambroxol hydrochloride in the management of idiopathic pulmonary fibrosis: Clinical trials are the need of the hour.

Authors:  P R Gupta
Journal:  Lung India       Date:  2014-01

10.  Ambroxol for the treatment of fibromyalgia: science or fiction?

Authors:  Kai-Uwe Kern; Myriam Schwickert
Journal:  J Pain Res       Date:  2017-08-16       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.